IL114129A0 - Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
IL114129A0
IL114129A0 IL11412995A IL11412995A IL114129A0 IL 114129 A0 IL114129 A0 IL 114129A0 IL 11412995 A IL11412995 A IL 11412995A IL 11412995 A IL11412995 A IL 11412995A IL 114129 A0 IL114129 A0 IL 114129A0
Authority
IL
Israel
Prior art keywords
treatment
composition
withdrawal symptoms
nicotine craving
smoking withdrawal
Prior art date
Application number
IL11412995A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL114129A0 publication Critical patent/IL114129A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
IL11412995A 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms IL114129A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26426294A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
IL114129A0 true IL114129A0 (en) 1995-10-31

Family

ID=23005260

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11412995A IL114129A0 (en) 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2703695A (xx)
IL (1) IL114129A0 (xx)
MA (1) MA23588A1 (xx)
PE (1) PE33396A1 (xx)
WO (1) WO1996000071A1 (xx)
ZA (1) ZA955032B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US20110053988A1 (en) * 2009-08-29 2011-03-03 Jorge Alberto Cassara Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
MX2018012439A (es) * 2016-04-12 2019-02-21 Solis Herrera Arturo Composiciones y metodos para el tratamiento de enfermedades de la mucosa nasal y paranasal con agonistas del receptor de acetilcolina de tipo nicotinico.
WO2019200427A1 (en) * 2018-04-16 2019-10-24 Barista Mist Pty Ltd Caffeine compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency

Also Published As

Publication number Publication date
PE33396A1 (es) 1996-08-19
WO1996000071A1 (en) 1996-01-04
ZA955032B (en) 1996-03-11
MA23588A1 (fr) 1995-12-31
AU2703695A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0713655A3 (en) Cigarette substitute and process for its manufacture
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EP0632969A3 (de) Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung.
EP0777473A4 (en) PREPARATIONS AND METHOD FOR CONTROLLING SMOKING
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
ZA938094B (en) Process for adjesting the moisture content of tobacco
EP0632968A3 (de) Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung.
IL126683A0 (en) Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
IL114130A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
GB9404707D0 (en) Filter for smoking article and smoking article incorporating it
EP0496148A3 (en) Improvements in the treatment of ashes
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
GB2222066B (en) Method of increasing the hardness of cigarette filter elements
GB9410482D0 (en) Tobacco smokers' mouthpiece
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
AU2100188A (en) Nicotine level reduction in cigarettes
GB9304027D0 (en) Packet for blocks of cigarettes and the like
ZA959717B (en) Tobacco rod and/or filter for smoking article
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
AU2107097A (en) Smoking mixture for use in the treatment of drug dependency
GB9325247D0 (en) Smokers'ashtray
HUP9601880A3 (en) Cigarette short of nicotine